Purpose To review published data pertaining to the clinical experience with a
dexamethasone intravitreal implant (Ozurdex®) with a view to establishing a clinically based …

Background Central retinal vein occlusion (CRVO) is a common retinal vascular abnormality
associated with conditions such as hypertension, diabetes, glaucoma, and a wide variety of …

Purpose.: We evaluated the association of angiogenic and inflammatory cytokine levels in
the aqueous humor with development of retinal ischemia and recurrent macular edema in …

Aims Retinal vein occlusion (RVO) is the most frequent retinal vascular disease after
diabetic retinopathy in which arterial risk factors are much more relevant than venous …

Purpose Among the retinal vascular diseases, burden of retinal vein occlusion is most
common immediately after diabetic retinopathy. Intravitreal corticosteroids are gaining …

Purpose: To evaluate the efficacy and safety of dexamethasone intravitreal implant 0.7 mg
(DEX) as adjunctive therapy to ranibizumab in neovascular age-related macular …

Purpose: To report adverse events after treatment of macular edema secondary to retinal
vein occlusion with intravitreal dexamethasone implant (IDI) in a UK center across three …

Background Concerns about the generalizability of pivotal randomized controlled trials
(pRCTs) findings have been raised. We aimed to compare intravitreal dexamethasone …

Aim To evaluate changes in the ischaemic index (ISI) after targeted retinal photocoagulation
(TRP) and to investigate the correlation between these changes and macular oedema (ME) …

Purpose. To evaluate the efficacy and safety of a single intravitreal dexamethasone implant
(DXI) combined with intravitreal antivascular endothelial growth factor (anti‐VEGF) therapy …